Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

New England Journal of Medicine

Volumn 335, Issue 4, 1996, Pages 233-241

  Gao, Shou Jiang ^a   Kingsley, Lawrence ^c   Hoover, Donald R ^d   Spira, Thomas J ^e   Rinaldo, Charles R ^c   Saah, Alfred ^d   Phair, John ^f   Detels, Roger ^g   Parry, Preston ^a   Chang, Yuan ^b   Moore, Patrick S ^a  

^a Columbia University ^*  (United States)

^b The New York Presbyterian Hospital   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CELL NUCLEUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; KAPOSI SARCOMA; LATENT VIRUS INFECTION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SINGLE BLIND PROCEDURE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; HEMOPHILIA A; HERPESVIRIDAE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; IMMUNOBLOTTING; MALE; NUCLEAR PROTEINS; SARCOMA, KAPOSI; SENSITIVITY AND SPECIFICITY;

EID: 8944226103     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199607253350403     Document Type: Article

References (43)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9.
2. Moore PS, Gao S-J, Dominguez, G, et al. Primary characterization of a herpesvirus-like agent associated with Kaposi's sarcoma. J Virol 1996;70: 549-58.
3. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995;332:1181-5.
4. Dupin N, Grandadam M, Calvez V, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995; 345:761-2.
5. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's-sarcoma-associted herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995;345: 1043-4.
6. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995;1:707-8.
7. Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Arch Intern Med 1996;156:202-4.
8. Rangan SR, Martin LN, Enright FM, Abee CR. Herpesvirus saimiri-induced lymphoproliferative disease in howler monkeys. J Natl Cancer Inst 1977;59:165-71.
9. Miller G. The oncogenicity of Epstein-Barr virus. J Infect Dis 1974; 130:187-205.
10. Levy JA. A new human herpesvirus: KSHV or HHV8? Lancet 1995; 346:786.
11. Roizman B. New viral footprints in Kaposi's sarcoma. N Engl J Med 1995;332:1227-8.
12. Strathdec SA, Veugelers PJ, Moore PS. The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery. AIDS 1996;10:Suppl: S51-S57.
13. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
14. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995;86:2708-14.
15. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-8.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
17. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4.
18. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996;10:175-80.
19. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976; 17:1-7.
20. Luka J, Kallin B, Klein G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyratc. Virology 1979;94:228-31.
21. zur Hausen H, O'Neill FJ, Freese UK, Hecker E. Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 1978;272:373-5.
22. Miller G, Rigsby MO, Heston L, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 1996;334:1292-7.
23. Pagano JS. Epstein-Barr virus: therapy of active and latent infection. In: Jeffries DJ, De Clercq E, eds. Antiviral chemotherapy. Chichester, England: John Wiley, 1995:155-95.
24. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996;2:342-6.
25. Henle W, Henle G, Andersson J, et al. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci U S A 1987; 84:570-4.
26. Rahman MA, Kingsley LA, Breinig MK, et al. Enhanced antibody responses to Epstein-Barr virus in HIV-infected homosexual men. J Infect Dis 1989;159:472-9.
27. Seigneurin JM, Lavoue MF, Genoulaz O, Bornkamn GW, Lenoir GM. Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals. Int J Cancer 1987;40:349-53.
28. Lennette ET, Rymo L, Yadav M, et al. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6. Eur J Cancer 1993;29A:1584-9.
29. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335:123-8.
30. Beral V, Bull D, Darby S, et al. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 1992;339:632-5.
31. Bowen DL, Lane HC, Fauci AS. Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:704-9.
32. Tappero JW, Conant MA, Wolfe SF, Berger TG. Kaposi's sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993;28:371-95.
33. Johnson PD, Graves SR, Stewart L, Warren R, Dwyer B, Lucas CR. Specific syphilis serological tests may become negative in HIV infection. AIDS 1991;5:419-23.
34. Hicks CB, Benson PM, Lupton GP, Tramont EC. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma: a diagnostic dilemma. Ann Intern Med 1987;107:492-5. [Erratum, Ann Intern Med 1987;107:946.]
35. Zalka A, Grossman ME, Silvers DN. "Seronegative" syphilis in AIDS. Ann Intern Med 1991;114:521-2.
36. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
37. Rady PL, Yen A, Rollefson JL, et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995; 345:1339-40.
38. Lin J-C, Lin S-C, Mar E-C, et al. Is Kaposi's-sarcoma-associated herpesvirus detectable in semen of HIV-infectcd homosexual men? Lancet 1995;346:1601-2.
39. Monini P, de Lellis L, Fabris M, Rigolin F, Cassai E. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human se men. N Engl J Med 1996;334:1168-72.
40. Adams V, Kempf W, Schmid M, Müller B, Briner J, Burg G. Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet 1995;346:1715-6.
41. Boshoff C, Talbot S, Kennedy M, O'Leary J, Schulz T, Chang Y. HHV8 and skin cancers in immunosuppressed patients. Lancet 1996;347: 338-9.
42. Gupta P, Mandaleshwar DS, Rinaldo C, et al. Detection of Kaposi's sarcoma herpesvirus DNA in semen of homosexual men with Kaposi's sarcoma. AIDS (in press).
43. Liebowitz D, Kieff E. Epstein-Barr virus. In: Roizman B, Whitley RJ, Lopez C, eds. The human herpesviruses. New York: Raven Press, 1993: 107-72.